The venture capital arm of CVS Health participated in a $65 million funding round in September for Redesign Health, which provides research, technology and branding for aspiring digital health companies. UPMC Enterprises and General Catalyst also took part.
“Redesign for us was a bit of a nontraditional investment, meaning it’s a launching pad for other startups. It has this multiplier effect in the digital health ecosystem,” said Andrea Messina, executive director and partner at CVS Health Ventures, in a July 12 CVS blog post. “They take a lot of the most difficult elements of starting a new company out of the equation for [prospective] founders. We’re really excited and enthusiastic for all they’ve been able to build.”
Redesign Health has helped 50 digital health startups get off the ground in the past five years, according to the article. CVS Health Ventures, meanwhile, has invested in 18 companies since it began doing business in April 2021.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
